Drug name - Tricor

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions Feb, 2023

(4 months from now)

US7276249 ABBVIE Nanoparticulate fibrate formulations Feb, 2023

(4 months from now)

Drugs and Companies using FENOFIBRATE ingredient

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v)


More Information on Dosage
Strength Dosage Availability
48MG TABLET;ORAL Prescription
145MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.